Corporate Governance Standing Committees
As at 30 April 2026, the Company’s issued share capital consists of 220, 114, 164 ordinary shares with a nominal value of 5p each (“Ordinary Shares”), each share having equal voting rights.
| Shareholders | 30-April-2026 | % IC |
|---|---|---|
| Octopus Investments Limited | 20,846,650 | 9.47% |
| Rathbone plc | 15,374,405 | 6.98% |
| Briarwood Chase Mgt | 14,430,432 | 6.56% |
| Canaccord Genuity Group Inc | 13,276,829 | 6.03% |
| Compagnie Odier SCA | 11,297,046 | 5.13% |
| Raymond James Financial | 9,485,552 | 4.31% |
| Blackrock Inc | 7,021,846 | 3.19% |
In accordance with the AIM Rules (Rule 26), insofar as the Company is aware as at 30 April 2026, the percentage of the Company’s issued share capital that is not in public hands is 2.64%. The free float percentage consists of the holdings not held by Directors, connected persons, the Company’s Share Incentive Plan (SIP) or significant shareholders (>10%). The Company’s free float is 97.36%.
Any corporate shareholders who wish to contact AMS, or provide information on their shareholding, can send an email to companysecretary@admedsol.com.